Ignite Creation Date:
2024-05-05 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00482053
Status:
TERMINATED
Last Update Posted:
2018-05-14
First Post:
2007-05-31
Brief Title:
Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT
Sponsor:
Stanford University
Organization:
Stanford University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Malignant Lymphoma Non-Hodgkin |
| Lymphoma B-cell |
| Lymphoma Non-Hodgkin |
| Diffuse Large B-cell Lymphoma DLBCL |
Keywords: